UNIVERSITATSKLINIKUM HAMBURG E has a total of 18 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are IMBA INST FUR MOLEKULARE BIOTECHNOLOGIE GMBH, KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN and CALYDON INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | United States | 5 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Analysing materials | |
#7 | Special acyclic compounds | |
#8 | Implantable devices | |
#9 | Syringes | |
#10 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Block Andreas | 5 |
#2 | Sauter Guido | 3 |
#3 | Simon Ronald | 3 |
#4 | Holst Frederik | 3 |
#5 | Gehling Ursula | 3 |
#6 | Turzynski Andreas | 2 |
#7 | Terracciano Luigi | 2 |
#8 | Lebeau Annette | 2 |
#9 | Loges Sonja | 2 |
#10 | Bremer Kai | 1 |
Publication | Filing date | Title |
---|---|---|
US2010136029A1 | Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies | |
WO2008029251A2 | Method for the detection of cancerous epithelial cells using released cytokeratins as markers for said cells | |
US2008027413A1 | Blood Products from Mesenchymal Stem Cells | |
AU2003229625A1 | Recombinant viral vectors for the tetracycline-regulated expression of genes |